BIAF 0.97 (-10.19%)
US09076W1099Medical Diagnostics & ResearchDiagnostics & Research

BioAffinity Technologies (BIAF) Competitor Comparison

We are evaluating the key criteria listed to compare BioAffinity Technologies (BIAF) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - BIAF ranking 49 / 58

These are the competitors of BioAffinity Technologies in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
100.26
2. Inotiv NOTV
85.96
3. Qiagen QGEN
47.04
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. DarioHealth DRIO
31.71
6. Syneos Health SYNH
24.79
7. Heska HSKA
15.42
8. Anixa Biosciences ANIX
13.68
9. CareDx CDNA
12.51
10. Fulgent Genetics FLGT
10.19
11. Charles River Laboratories CRL
9.94
12. Icon ICLR
8.67
13. Olink Holding OLK
8.53
14. Pacific Biosciences of California PACB
8.19
15. Exact Sciences EXAS
7.89
16. NeoGenomics NEO
7.07
17. IQVIA Holdings IQV
6.62
18. Myriad Genetics MYGN
6.57
19. DexCom DXCM
6.24
20. Aspira Womens Health AWH
5.9
21. Bioventus BVS
5.54
22. Interpace Biosciences IDXG
5.4
23. Guardant Health GH
5.05
24. PerkinElmer PKI
4.97
25. Trinity Biotech TRIB
4.93
26. Personalis PSNL
4.52
27. IDEXX Laboratories IDXX
4.3
28. Mettler-Toledo MTD
4.25
29. Sera Prognostics SERA
4.22
30. Thermo Fisher Scientific TMO
4.09
31. Quest Diagnostics DGX
4.02
32. Illumina ILMN
3.99
33. Agilent Technologies A
3.79
34. Danaher DHR
3.76
35. Neogen NEOG
3.71
36. Sotera Health SHC
3.69
37. Enzo Biochem ENZ
3.59
38. Laboratory Corp of America Holdings LH
3.55
39. Twist Bioscience TWST
3.33
40. Waters WAT
3.02
41. National Research NRC
2.95
42. Psychemedics PMD
2.62
43. Precipio PRPO
2.6
44. Neuronetics STIM
2.28
45. Exagen XGN
2.24
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
2.1
48. MaxCyte MXCT
1.95
49. bioAffinity Technologies BIAF
1.93
50. Biodesix BDSX
1.84
51. Prenetics Global PRE
1.81
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.59
56. Natera NTRA
0.59
57. Lantheus Holdings LNTH
0.47
58. RadNet RDNT
0.35

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.